[ Price : $8.95]
FDA approves a new indication for Bristol-Myers Squibbs Orencia to prevent acute graft versus host disease in combination with imm...[ Price : $8.95]
FDA approves a Pfizer supplemental NDA for its JAK inhibitor Xeljanz /Xeljanz XR (tofacitinib) for treating adults with active ank...[ Price : $8.95]
Federal Register notice: FDA announces a 2/10/2022 Oncologic Drugs Advisory Committee meeting that will vote on an Innovent Biolog...[ Price : $8.95]
Federal Register notice: FDA withdraws approval of six ANDAs from multiple applicants after they notified the agency that the prod...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled Expanded Access to Investigational Drug...[ Price : $8.95]
Pfizer says new data on its Covid-19 oral antiviral drug Paxlovid (nirmatrelvir tablets and ritonavir tablets) show the drug signi...[ Price : $8.95]
FDA warns Houstons Cooper Institute for Advanced Reproductive Medicine about significant deviations from the regulations for human...[ Price : $8.95]
FDA issues a guidance modifying REMS requirements for Genentechs Actemra under certain conditions during the Covid-19-related Acte...